Company’s Chief Strategy and Innovation Officer Purchases 605 Shares of $CHRW

ARUN RAJAN, the Chief Strategy and Innovation Officer at $CHRW, recently acquired 605 shares of the company on 02-12-2026, amounting to an estimated value of $101,102. This trade, as revealed by Quiver Quantitative’s analysis of a recent SEC filing, led to an increase in their ownership of this particular class of stock by roughly 0.5%. Consequently, they now possess 133,656 shares of $CHRW stock.

Over the past six months, insiders at $CHRW have engaged in 12 transactions involving the company’s stock, with 2 instances of purchases and 10 instances of sales. Notably, key figures such as ANGELA K. FREEMAN, the CHRO and ESG Officer, have made no purchases but have conducted 3 sales amounting to 58,463 shares, valued at approximately $9,188,154. Similarly, MICHAEL D. CASTAGNETTO, the President of NAST, has executed 3 sales of 48,115 shares totaling $7,419,961. In contrast, MICHAEL JOHN SHORT, the President of Global Forwarding, did not make any purchases but sold 7,598 shares for $1,497,128. ARUN RAJAN, the Chief Strategy and Innovation Officer, not only bought 605 shares worth $101,102 but also sold 5,000 shares for $686,275 in two separate transactions. Further, DAMON J. LEE, the Chief Financial Officer, acquired 620 shares for $100,763.

Moving on, let’s delve into hedge fund activities related to $CHRW. Notable changes include 399 institutional investors adding $CHRW shares to their portfolio, while 344 decreased their positions in the most recent quarter. Significant movements include WELLINGTON MANAGEMENT GROUP LLP increasing their holdings by 4,751,034 shares (+198.6%) in Q3 2025, valued at an estimated $629,036,901. Conversely, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, removed 2,513,319 shares (-72.2%) in Q4 2025, amounting to $404,041,162.

In terms of revenue, $CHRW recorded revenues of $3.9 billion in Q4 2025, reflecting a decrease of -6.5% compared to the same period in the previous year. For further financial insights on $CHRW, detailed data can be accessed on Quiver Quantitative’s dedicated stock page.

Congressional involvement in trading $CHRW stock has been minimal, with one instance recorded in the past 6 months where REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23. Analyst opinions and ratings regarding $CHRW have also been made available, with 10 firms affirming buy ratings and 1 suggesting a sell rating. Notable ratings include a “Buy” rating from Benchmark on 01/30/2026 and an “Underweight” rating from Morgan Stanley on 01/29/2026.

Overall, multiple analysts have offered price targets for $CHRW, with 17 analysts issuing targets in the last six months, reflecting a median target of $200.0. Recent targets include a $202.0 target price from Ariel Rosa at Citigroup on 01/30/2026 and a $205.0 target price from Christopher Kuhn at Benchmark on the same date. For comprehensive tracking of analyst ratings and price forecasts for $CHRW, refer to Quiver Quantitative’s specialized forecast page.